9th Annual European Drug Safety Pharma & Biotech Conference

World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour

key information

OUR STORY TO TELL THE WORLD

OUR CONFERENCE PROGRAM

This is not just another Drug safety conference. This is a conference which tells you a STORY. One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and to improve the health of millions of people on our planet. You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant. But how to do this with the more and more restrictive budget? How to prioritize, what methodologies to use for advanced therapies? What is the next evolution step in signal detection noise clearance? Are A.I.-based tools to become our colleagues, helpmates, or our replacement? Nonetheless, each company, department, and project starts with people. But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future? What kind of skills to expect from millennials and gen-z entering the industry and why do we need veterans in the industry as well? Challenges with innovations, outsourcing, everchanging regulatory landscape, harmonization, teaching other departments on how to use RWE data, and engaging the more and more aware public. All these topics we address, are conveyed having our mission in our mind, bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably. Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals. Our conference will feature numerous assisted formal and informal networking, matchmaking, and breakout sessions to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.

KEY TOPICS

Who will attend

5/5
I really like the event. I like the fact that a number of companies represented not only pharma companies, the biotech
Delegate
5/5
We’ve had a lot of discussion about trends in artificial intelligence and how they impact world of biopharma in general and project management in particular. So I’ll definitely be following up on some of the insights that have been shared around those.
Derek Shannon
Director Statistical Project Management, Madrigal Pharmaceuticals
5/5
Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.
Christine Clearwater
Healthcare Manager
5/5
I really enjoy this conference so far because as a senior project manager it’s been really helpful to see the ideas and exchange them with the other people in the industry.
David Rose
Senior Project Manager, CAI

Event Speakers

Petros Mavrogenis

Head Vigilance Process Excellence
Novartis

Sabine Poltermann

Country Head Patient Safety
BMS

Dimitris Zampatis

Global Program Safety Lead-TA Oncology & Immunology
Sandoz

Luvanka Hanxhari

Novartis

Ricarda Tiemeyer

Head of Pharmacovigilance
Biogen

Fiorenza Gaudenzi

Novartis

Marina Suvakov

Global Head, Product Safety Surveillance
Philip Morris International

Santanu Mukhopadhyay

Head of Medical Safety
Vectura Fertin Pharma

Ján Škrle

Head of Pharmacovigilance
Zentiva

Dmytro Horilyk

CEO
DrugCard

Jost Leemhuis

Roche

Sibel Guerler

Head of Innovation, Partnerships & Process Optimization, WorldWide Patient Safety
BMS

Erika Barbarossie

Associate director compliance
Gilead

Henk Streefkerk

CEO
Amarna Therapeutics

Mark Waring

Pharmacovigilance Services Industry Consultant

Graeme Ladds

Director
Pharsafer

Finn B. Larsen 

Head of Technology & Data Management, Patient Safety
Sandoz

Nikolina Nuic 

Safety Database Manager 
Philip Morris International

Felix Arenallo

Global Head of Drug Safety
Roche

Galina Cordero

Global Risk Management Plan Lead
Novartis
View More Speakers

AGENDA

VIEW ALL SESSIONS & THEIR DESCRIPTIONS

REGISTRATION

Conference

Ticket | November 29-30, 2023
2399
  • Access to All Conference Sessions of the 9th Annual European Drug Safety Pharma & Biotech Conference Basel
  • Access to Post Conference Networking
  • Conference Materials
  • Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch

BECOME A PARTNER

OF this EVENT
  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits

event partners

GOLD SPONSOR

Founded in 2003 by Dr Graeme Ladds, PharSafer® is a specialist Contract Research Organisation (CRO) in Global Clinical and Post Marketing Drug Safety, and Medical Services, with a wealth of experience in Pharmacovigilance, Auditing and Medical Affairs – and the various, numerous and extensive legal safety/medical obligations for licence holders to comply with – as well as Regulatory Strategy for the best methods for obtaining scientific advice concerning licence submissions and approvals.

Our ability to offer first-class services in Pharmacovigilance, Regulatory Strategy, Training, Auditing, Medical Affairs and IT Informatics means that, for many clients, we operate as their Pharmacovigilance and Medical Departments, guiding them through the labyrinth of drug safety and medical legislation – all in the interests of ensuring patient safety safety and client compliance.

SILVER SPONSOR

Dr. Waring, a licensed physician with extensive clinical and research experience, specializes in clinical drug safety, pharmacovigilance, and pharmaceutical risk management. With nearly 25 years of industry and consulting experience, he has designed and prepared numerous risk management plans for a wide range of products. He has a strong track record of delivering high-quality results on time, meeting regulatory expectations, and has expertise in global and EU pharmacovigilance requirements. Dr. Waring has also led quality improvement initiatives and provided training and coaching in pharmacovigilance and pharmacoepidemiology. His areas of interest include drug hepatotoxicity evaluation and the safety of biological therapeutics.

BRONZE SPONSOR

The Ennov Group is a software vendor specialized in pharmacovigilance, clinical trials management (Data Management, eCRF, Monitoring, Randomization), document management, regulatory submission lifecycle (eCTD), and business process management (Deviation, CAPA, Audits, Change Control, Training).
Headquartered in Paris, with offices in the US, UK, Tunisia & Vietnam, Ennov provides an intuitive and unified content and information management platform to support and enrich the entire Life Sciences product life cycle. It offers comprehensive and flexible tools helping you align your daily activities with respect to the regulatory requirements of the pharmaceutical industry (ICH, EMEA) and FDA recommendations (21CFR, part 11). With more than 250 customers worldwide in Life Sciences, Ennov has become “the solution of choice” in the international software for pharmaceuticals market.

PANEL SPONSOR

DrugCard is the vanguard in AI-enabled pharmacovigilance solutions, modernizing drug safety practices across the globe. Our platform is designed to automate local literature screening, making it continuous, regular, transparent, multi-language, and cost-effective. And Why Choose DrugCard?

– AI-Enabled Efficiency: Leveraging advanced AI technology, DrugCard streamlines drug safety routines, reducing literature screening time by an impressive 70%.
– Global Reach with Local Expertise: DrugCard supports 100+ languages and covers medical journals in 45+ countries.
– Customizable Solutions: The only SaaS in the market that tailors its features to meet your specific needs. From automatic translation to user role management, we offer a suite of customizable features.
– Real-Time Analytics: platform provides real-time analysis, enabling pharmacovigilance teams to proactively identify new safety signals and evaluate risks, thereby enhancing patient safety.

AGENDA DOWNLOAD